Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q10382411> ?p ?o }
Showing triples 1 to 24 of
24
with 100 triples per page.
- Q10382411 subject Q15305141.
- Q10382411 subject Q52333.
- Q10382411 subject Q9622428.
- Q10382411 abstract "Tideglusib (NP-12, NP031112) is a potent, selective and irreversible small molecule non-ATP-competitive GSK3 inhibitor that has been investigated as a potential treatment for Alzheimer's disease and paralysis supranuclear palsy in Phase IIa and IIb clinical trials. The first clinical trial conducted with tideglusib to be published (in English, at least) was phase II and demonstrated that overall tideglusib was well tolerated, except for some moderate, asymptomatic, fully reversible increases in liver enzymes (≥2.5xULN; where ULN=Upper Limit of Normal).".
- Q10382411 iupacName "4-Benzyl-2-(naphthalen-1-yl)-1,2,4-thiadiazolidine-3,5-dione".
- Q10382411 pubchem "11313622".
- Q10382411 thumbnail Tideglusib2DACS.svg?width=300.
- Q10382411 wikiPageWikiLink Q11081.
- Q10382411 wikiPageWikiLink Q15305141.
- Q10382411 wikiPageWikiLink Q52333.
- Q10382411 wikiPageWikiLink Q80863.
- Q10382411 wikiPageWikiLink Q910847.
- Q10382411 wikiPageWikiLink Q945930.
- Q10382411 wikiPageWikiLink Q9622428.
- Q10382411 iupacName "4".
- Q10382411 pubchem "11313622".
- Q10382411 type ChemicalSubstance.
- Q10382411 type Drug.
- Q10382411 type ChemicalObject.
- Q10382411 type Thing.
- Q10382411 type Q8386.
- Q10382411 comment "Tideglusib (NP-12, NP031112) is a potent, selective and irreversible small molecule non-ATP-competitive GSK3 inhibitor that has been investigated as a potential treatment for Alzheimer's disease and paralysis supranuclear palsy in Phase IIa and IIb clinical trials.".
- Q10382411 label "Tideglusib".
- Q10382411 depiction Tideglusib2DACS.svg.